Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

299

To be discontinued: 2 (1%)
Discontinued: 297 (99%)
Reversed: 0 (0%)

Late reports

361 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-02-17 2022-03-24 155155
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95373
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95378
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-11-01 95381
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-01-09 2020-02-21 102893
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-11-14 2023-01-12 174595
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-10-22 2020-11-12 126918
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Actual shortage 2024-06-07 2025-03-27 229963
DULOXETINE DR 60MG CAPSULE (DELAYED RELEASE) Resolved 2018-03-16 2018-11-08 43119
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2018-12-04 2019-08-06 68608
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2019-08-22 2019-10-24 92180
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2024-12-20 2025-01-18 246254
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2021-02-05 2021-03-11 133445
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-02-17 2023-04-28 185077
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-06-08 2023-10-03 194144
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-06-20 2023-07-05 195784
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-10-19 2023-11-30 207533
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Resolved 2017-03-13 2020-02-13 1691
EPTIFIBATIDE INJECTION 2MG SOLUTION Resolved 2017-03-13 2020-02-13 1694
ETOPOSIDE INJECTION 20MG LIQUID Resolved 2023-06-20 2023-07-28 195789

Showing 381 to 400 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-RISEDRONATE 150MG TABLET Discontinued 2021-02-12 2021-02-12 133905
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-04-29 2025-04-29 256079
TEVA-ROSUVASTATIN 5MG TABLET Discontinued 2022-03-25 2022-03-26 157428
TEVA-ROSUVASTATIN 10MG TABLET Discontinued 2022-03-25 2022-03-26 157431
TEVA-ROSUVASTATIN 20MG TABLET Discontinued 2022-03-25 2022-03-26 157434
TEVA-ROSUVASTATIN 40MG TABLET Discontinued 2022-03-25 2022-03-26 157437
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353
TEVA-TENOFOVIR 300MG TABLET Discontinued 2025-04-29 2025-04-29 256088
TEVA-TOPISONE 0.05% LOTION Discontinued 2024-06-28 2024-06-29 231589
TEVA-TOPOTECAN 4MG POWDER FOR SOLUTION Discontinued 2025-04-29 2025-04-29 256104
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-TRIAMTERENE/HCTZ 25MG 50MG TABLET Discontinued 2017-06-27 2017-06-27 14060
TEVA-TRIAMTERENE/HCTZ 50MG 25MG TABLET Discontinued 2020-05-14 2020-05-14 115091
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2018-10-19 2018-10-19 65017

Showing 261 to 280 of 299